Geng Integrity Report: "Prospects of Behavioral and Lifestyle Interventions for Diabetes" (DOI: 10.12114/j.issn.1007-9572.2025.0587)

Academic fraud report · Geng Detector

Summary

This Geng academic integrity screening report evaluates a narrative review article titled "Prospects of Behavioral and Lifestyle Interventions for Diabetes" by Tian Xiangyang, Zhou Yingsheng, and Gao Ying, published in Chinese General Practice (DOI: 10.12114/j.issn.1007-9572.2025.0587). The overall verdict is CLEAR (no academic misconduct detected). Because the paper is a narrative review with no original experimental data, Western blots, microscopy images, or flow cytometry figures, the report's core image-duplication and data-fabrication checks were not applicable. A timeline and citation-logic check passed: submission date 2025-12-16, revision date 2026-06-03, with a 2026 reference [65] (Kannenberg S, et al. J Diabetes Sci Technol) plausibly added during revision. One minor typographical/OCR glitch ("国2?7CD") was flagged in Section 3 as a proofreading error, not misconduct. Confidence is high for the inapplicability finding and timeline check, with the only limitation being reliance on the single supplied PDF.

Verdict

Clear / No academic misconduct detected. The paper is a narrative review with no original experimental data or images, so image-duplication, image-splicing, and raw-data-fabrication checks are not applicable. All cited quantitative results (e.g., MD=-0.61%, 95%CI values attributed to Romadlon et al.) are presented as references to prior published literature and are properly attributed.

Key findings

Paper type shields it from data-fabrication screening. The manuscript contains no original experimental figures (Western blots, microscopy, flow cytometry) and no author-generated data tables; only summarized literature statistics are present, all with source citations.
Timeline and citation logic are consistent. Received 2025-12-16, revised 2026-06-03. References [7] and [8] (2025 Chinese and US BLI guidelines) support the in-text claim that both countries released diabetes BLI guidelines in 2025. Reference [65] (Kannenberg S, et al., J Diabetes Sci Technol, 2026, 20(1)) is plausibly added during the revision stage given the 2026-06-03 revision date.
Minor proofreading issue identified. Section 3 ("Lifestyle interventions moving toward precision"), second paragraph, contains a garbled fragment "国2?7CD" inside the sentence describing Ehrhardt et al. [25]'s CGM-coupled dietary guidance study. This appears to be an OCR/typesetting artifact (likely intended to express "better identify/understand"), not an integrity issue.
No action items for PubPeer or raw-data requests. No basis exists to contact the authors for underlying data or to post a public concern.

Evidence highlights

DOI: 10.12114/j.issn.1007-9572.2025.0587 (Chinese General Practice, 2026)
Source file: 202606.00091v1.pdf
Authors: Tian Xiangyang, Zhou Yingsheng, Gao Ying
Quantitative example cited: MD=-0.61% (95%CI implied), attributed to Romadlon et al.
Newest reference: [65] Kannenberg S, et al. J Diabetes Sci Technol, 2026, 20(1) — consistent with the 2026-06-03 revision date
Typographical defect: "国2?7CD" in Section 3, paragraph 2

Notes

Limitations. The assessment is based solely on the supplied PDF; the authors' raw data were not requested because none are claimed. The literature-citation accuracy of secondary references (e.g., Romadlon et al.) was not independently re-verified against the primary sources within this screening.
Recommendation. Optional editorial fix: correct the "国2?7CD" typesetting/OCR error in Section 3 of the published version. No integrity-related follow-up is warranted.
Disclaimer. This report is AI-assisted, intended for academic discussion only, and does not constitute a formal investigation finding.